Duoneb

drugbox
IUPAC_name = TBD


width = TBD
CAS_number = TBD
ATC_prefix = TBD
ATC_suffix = TBD
PubChem = TBD
DrugBank = TBD
chemical_formula = (C₁₃H₂₁NO₃)₂ * H₂SO₄ +
C₂₀H₃₀BrNO₃ * H₂O
molecular_weight = TBD g/mol
bioavailability =
protein_bound = TBD%
metabolism = TBD
elimination_half-life = TBD hours
excretion = TBD
pregnancy_category = TBD
legal_status = TBD
routes_of_administration = Oral

Duoneb is a combination of two bronchodilators, albuterol sulfate and ipratropium bromide. It is used to treat symptoms (ie, bronchospasms) in patients with lung disease (ie, chronic obstructive pulmonary disease or COPD). It is commonly administered using a nebulizer.

Duoneb is marketed by Dey, L.P. (Napa, California) under the brand name DuoNeb. It is available as a fluid (for use with a nebulizer).

Subject of recent Medicare and FDA controversy. FDA has moved for regulation of generic competition to commercial product whereas Medicare has moved to limit reimbursement of commercial product. Dispute resolution will have a material economic impact on leading respiratory service providers.

External links

* [http://www.duoneb.com DuoNeb Official Website]
* [http://www.dey.com Dey, L.P. Home Page]